Publications

5600 Results

Medical-aid-in-dying use in the US Pacific Northwest

Authors
CD Blanke;M Leblanc;D Hershman;FL Meyskens;LP Taylor;LM Ellis
Journal / Conference
Annals of Oncology, Volume 29, Issue suppl_8, 1 October 2018, mdy295.026, #1537P, poster presentation (ESMO)
Year
2018
Research Committee(s)
Cancer Care Delivery

Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review [Review]

Authors
AM Kamat;R Li;MA O'Donnell;PCV Black;M Roupret;JW Catto;E Comperat;MA Ingersoll;WP Witjes;DJ McConkey;JA Witjes
Journal / Conference
European Urology May;73(5):738-748
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29055653
Study Number(s)
SWOG-8795 (INT-0094) (EST-1888)

Identification of Risk Factors for Toxicity in Patients With Hormone Receptor-Positive Advanced Breast Cancer Treated With Bevacizumab Plus Letrozole: A CALGB 40503 (Alliance) Correlative Study

Authors
D Li;L McCall;O Hahn;C Hudis;H Cohen;H Muss;A Jatoi;J Lafky;K Ballman;E Winer;D Tripathy;B Schneider;W Barry;M Dickler;A Hurria
Journal / Conference
Breast Cancer Research and Treatment 171 (2):325-334
Year
2018
Research Committee(s)
Breast
PMID
PMID29789969
PMC
PMC6076849
Study Number(s)
CTSU/C40503

Seven year follow-up for energy/vitality outcomes in early stage hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208

Authors
C Moinpour;J Unger;P Ganz;T Wang;A Kornblith;E Gaynor;MA Bowers;S Balcerzak;G Gatti Gunderson;Mark Kaminski;H Erba;O Press;RI Fisher
Journal / Conference
Journal of Cancer Survivorship:Research and Practice, 2017 Feb;11(1):32-40; 2016 Jul 12 [Epub ahead of print]
Year
2017
Research Committee(s)
Lymphoma
PMID
PMID27405732
PMC
PMC5233644
Study Number(s)
SWOG-9133, SWOG-9208

Next-generation sequencing in adult B cell acute lymphoblastic leukemia patients

Authors
O Sala-Torra;M Othus;D Willliamson;B Wood;J Kirsch;H Robins;L Beppu;M O'Donnell;S Forman;F Appelbaum;J Radich
Journal / Conference
Biology of Blood and Marrow Transplantation Apr;23(4):691-696; Epub 2017 Jan 3.
Year
2017
Research Committee(s)
Leukemia
PMID
PMID28062215
PMC
PMC5465962
Study Number(s)
S0333

Osteoporosis therapy prolongs event-free survival in post-menopausal breast cancer patients randomized to adjuvant exemestane or anastrozole: NCIC CTG MA.27

Authors
A Lipton;JW Chapman;K Leitzel;A Garg;K Pritchard;J Ingle;G Budd;M Ellis;G Sledge;M Rabaglio;L Han;C Elliott;LE Shepherd;PE Goss;S Ali
Journal / Conference
Cancer Jul 1;123(13):2444-2451. Epub 2017 May 2.
Year
2017
Research Committee(s)
Breast
PMID
PMID28464211

Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials

Authors
H Greenlee;J Unger;M Leblanc;S Ramsey;D Hershman
Journal / Conference
Cancer Epidemiology Biomarkers & Prevention 2017 Jan;26(1):21-29; 2016 Dec 16. [Epub ahead of print]
Year
2017
Research Committee(s)
Breast, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, Lymphoma, and Sarcoma
PMID
PMID27986655
PMC
PMC5370550
Study Number(s)
S0033, S0221, SWOG-8507, SWOG-8516 (INT-0067), SWOG-8600, SWOG-8706, SWOG-8736 (INT-0093), SWOG-8795 (INT-0094) (EST-1888), SWOG-8814, SWOG-8897, SWOG-8949, SWOG-9012, SWOG-9031, SWOG-9333, SWOG-9346, SWOG-9420, SWOG-9500, SWOG-9509, S9701, S9916

Prognostic methylation markers for survival in cytogenetically normal AML patients treated on SWOG trials

Authors
X Qu;M Othus;J Davison;Y Wu;L Yan;E Estey;J Radich;H Erba;F Appelbaum;M Fang
Journal / Conference
Cancer Jul 1;123(13):2472-2481; 2017 Feb 21[Epub ahead of print]
Year
2017
Research Committee(s)
Leukemia
PMID
PMID28222251; PMC5705230
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500, S9918

A pooled analysis of 15 prospective cohort studies on the association between fruit, vegetable, and mature bean consumption and risk of prostate cancer

Authors
J Petimar;KM Wilson;K Wu;D Albanes;P van den Brandt;MB Cook;GG Giles;GE Goodman;P Goodman;N Haansson;K Helzlsouer;L Kolonel;L Liao;S Mannisto;M McCullough;R Milne;M Neuhouser;Y Park;EA Platz;N Sawada;J Schenk Kisser;S Tsugane;B Verhage;M Wang;Y Wang;L Wilkens;R Ziegler;S Smith-Warner;J Schenk
Journal / Conference
Cancer Epidemiology Biomarkers & Prevention Aug;26(8):1276-1287; Apr 26 [Epub ahead of print]
Year
2017
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID28446545
PMC
PMC5540798
Study Number(s)
SWOG-9217

A randomized phase II study of azacitidine alone or in combination with lenalidomide or with vorinostat vs. azacitidine monotherapy in higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML): North American Intergroup Study SWOG S1117

Authors
M Sekeres;M Othus;AF List;O Odenike;RM Stone;S Gore;M Litzow;R Buckstein;M Fang;D Roulston;C Bloomfield;A Moseley;Y Zhang;MR Velasco;R Gaur;E Attallah;E Attar;MJ Rauh;F Appelbaum;H Erba
Journal / Conference
Journal of Clinical Oncology Aug 20;35(24):2745-2753; 2017 May 9 [Epub ahead of print]
Year
2017
Research Committee(s)
Leukemia
PMID
PMID28486043; PMC5562170
Study Number(s)
S1117